patent.fyi
Applications  /  US 2026/0356865
United States Patent Application Publication

US 2026/0356865 A1

Published
Nov 12, 2026
Filed
Sep 21, 2023
Earliest date on the face
Sep 21, 2022
Classification
C07F 9/5728
First published here
Nov 20, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Benzyl substitution on nitrogen

What ifWhat if one side-chain nitrogen substituent is benzyl and the other is methyl?
Claim language“each R is independently C1-6 alkyl”

An N-benzyl-N-methyl tryptamine precursor supplies the tertiary side-chain amine. Phosphorylation of the phenolic oxygen at position 4 and subsequent phosphate deprotection produce the corresponding phosphate monoester.

1.2Phosphoramidite coupling and oxidation

What ifWhat if a dibenzyl phosphoramidite supplies the phosphorus group?
Claim language“with (R′O)2POCl”

An azole activator promotes coupling of the phenolic oxygen to dibenzyl N,N-diisopropylphosphoramidite. An organic hydroperoxide oxidizes the resulting phosphite triester to the dibenzyl-protected phosphate.

1.2Phosphate transfer through imidazole

What ifWhat if a dibenzyl phosphorimidazolide transfers the phosphorus group to the phenolic oxygen?
Claim language“with (R′O)2POCl”

The phenoxide attacks the pentavalent phosphorus center and displaces the imidazole-derived leaving group. The resulting phosphate triester retains both benzyl groups for subsequent deprotection.

1.3Seven-carbon phosphate protecting groups

What ifWhat if both R′ groups are straight-chain heptyl groups?
Claim language“each R′ is independently selected from C1-6 alkyl, —CH2-aryl and —CH2-heteroaryl”

Bis(n-heptyloxy)phosphoryl chloride transfers a phosphate group bearing two primary heptyl esters to the phenolic oxygen. Bromotrimethylsilane cleaves the primary alkyl groups, and hydrolysis of the resulting silyl esters gives the phosphate monoester.

1.4Hydrogenolysis of benzyl phosphate esters

What ifWhat if catalytic hydrogenolysis removes both benzyl groups from the protected phosphate?
Claim language“further reacted with TMSBr”

Hydrogen and a supported palladium catalyst cleave the two benzylic carbon–oxygen bonds of the dibenzyl phosphate intermediate. The cleavage exposes both phosphate hydroxyl groups while retaining the bond between phosphorus and the phenolic oxygen.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Isotope labeling for analytical reference materials

An analytical laboratory uses a phenolic tryptamine intermediate bearing two carbon-13-labeled N-methyl groups. Diethyl phosphorochloridate phosphorylates the phenolic oxygen, and trimethylsilyl bromide removes the ethyl groups from the phosphate. Liquid chromatography with mass spectrometry distinguishes the labeled material from the unlabeled analyte and measures their peak area ratio for isotope dilution.

Component substitution

Hydrogenolysis of a dibenzyl phosphate intermediate

Dibenzyl phosphorochloridate converts the phenolic intermediate into a dibenzyl phosphate ester. Hydrogen and palladium on carbon replace trimethylsilyl bromide in the deprotection step. Liquid chromatography tracks cleavage of both benzyl groups and checks for reduction of the indole ring before catalyst filtration.

Phosphoramidite coupling followed by phosphorus oxidation

Diethyl N,N-diisopropylphosphoramidite replaces the phosphorochloridate as the phosphorus donor. Tetrazole activates the phosphoramidite for coupling with the phenolic oxygen to form a phosphite triester. Iodine in aqueous pyridine oxidizes the phosphite to a phosphate triester, which is isolated and dried before treatment with trimethylsilyl bromide.

Parameter or scale variation

Microscale reactions in parallel glass vials

A screening rack holds eight 2 mL glass vials, each charged with 50 micromoles of the phenolic intermediate and a magnetic stir bar. The protected phosphate forms in each vial and is isolated before redissolution at 0.10 molar in dry dichloromethane. The rack holds the vials at 20 °C during trimethylsilyl bromide treatment, with separate aliquots quenched for analysis at 30, 60 and 120 minutes.

Combination with existing systems

Phosphate purification by preparative reversed phase chromatography

An aqueous quench and phase separator connect the deprotection reactor to a preparative liquid chromatography system. The clarified aqueous stream enters a C18 column through a sample loop. A water and acetonitrile gradient containing ammonium formate separates the phosphorylated product from residual phenolic precursor and organic byproducts. A fraction collector pools the product peak, and lyophilization removes the mobile phase.

Automated or data-driven variant

Chromatography controlled phosphate deprotection endpoint

An automated sampler withdraws aliquots from the stirred deprotection reactor and quenches them in a separate vial before injection into a liquid chromatograph. The software integrates the peaks for the protected phosphate, the partially deprotected phosphate and the final product using calibrated response factors. After two consecutive samples meet the configured limits for residual esters, the controller ends the reaction hold and transfers the batch to a quench vessel.

Specific version of a part

Mixed methyl and ethyl substitution

One side-chain nitrogen substituent is methyl and the other is ethyl. The tertiary amine retains both substituents during phosphorylation of the phenolic oxygen.

Phenoxide coupling with dimethyl phosphoryl chloride

A base generates the phenoxide from the phenolic precursor. The phenoxide attacks dimethyl phosphoryl chloride and displaces chloride to form the dimethyl phosphate triester.

Mixed methyl and benzyl protection

The phosphoryl chloride bears one methoxy group and one benzyloxy group. Both groups remain attached to phosphorus when the phenolic oxygen replaces chloride.

Bromotrimethylsilane cleavage of methyl esters

Bromotrimethylsilane converts the two methyl phosphate esters to trimethylsilyl esters and releases methyl bromide. Water hydrolyzes the trimethylsilyl esters to give the phosphate monoester.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 8,017,797 B2
Published
Sep 13, 2011
Filed
Mar 21, 2008
Class
C07C 67/00
Document BUS 2018/0273575 A1
Published
Sep 27, 2018
Filed
May 31, 2018
Class
C07H 19/20
Claim 1
Document A
Document B
1.1each R is independently C1-6 alkyl, preferably methyl or ethyl
Preferably, R1 and R2 are C1-4 alkyl group, and more preferably methyl group and ethyl group.
A · US 8,017,797 B2 · ¶ 61
Preferably R3 is alkyl, more preferably R3 is selected from the group consisting of methyl, ethyl, 2-propyl, 2-butyl, —CH2—C(CH3)3 and benzyl, even more preferably R3 is selected from the group consisting of methyl (—CH3) and benzyl (—CH2C6H5).
B · US 2018/0273575 A1 · ¶ 71
1.2wherein the method comprises the step of reacting the compound of formula (Id) with (R′O)2POCl
Further specific examples of compounds of Formula I that can be suitably be prepared by the process of the present invention include phosphoramidated nucleosides prepared from compounds of Formula III which are any of the specific examples of the preferred phosphorochloridates listed above, in combination with compounds of Formula II which are any of the specific examples of the preferred nucleosides listed above.
B · US 2018/0273575 A1 · ¶ 97
1.3wherein each R′ is independently selected from C1-6 alkyl, —CH2-aryl and —CH2-heteroaryl
[in the formula, R1 representing C1-4 alkyl group, arylmethyl group, or substituted arylmethyl group; R2 represents C1-4 alkyl group, arylmethyl group, or substituted arylmethyl group];
A · US 8,017,797 B2 · ¶ 23
1.4wherein the product of the reaction of the compound of formula (Id) with said (R′O)2POCl is further reacted with TMSBr, resulting in the compound of formula (I).

An empty cell means only that no passage was reproduced there.

Statements in these documents
The present invention relates to a method for producing 4-(hydroxymethylphosphinyl)-2-oxobutanoic acid which is useful as a production intermediate of a herbicide;
A · US 8,017,797 B2 · ¶ 2
However, the production yield of 4-(hydroxymethylphosphinyl)-2-oxobutanoic acid is as low as about 40% in the synthesizing method of the patent document 4 using 3-(hydroxymethylphosphinyl)-propionate ester.
A · US 8,017,797 B2 · ¶ 15
A need thus exists to provide a more cost effective process for preparing a chiral compound for therapeutic use where the compound comprises at least an enriched portion of a desired enantiomer.
B · US 2018/0273575 A1 · ¶ 5
In particular, the present process provides a process for preparing phosphoramidates of nucleosides where a desired enantiomer, having regard to the asymmetric chiral centre of the phosphorus atom P, is provided in an enriched amount.
B · US 2018/0273575 A1 · ¶ 8
Cite aspatent.fyi, US 2026/0356865 A1, claim 1, first published 2026-11-20T08:11:50-05:00, https://patent.fyi/US20260356865/, SHA-256 62e57b68143a59af9f7b7676bd165b8bece95c684e62e576c5f7db9b4501cc1d
First published
Permanent addresshttps://patent.fyi/US20260356865/
Content fingerprint (SHA-256)62e57b68143a59af9f7b7676bd165b8bece95c684e62e576c5f7db9b4501cc1d
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi